S&P 500 Futures
(-0.15%) 5 139.25 points
Dow Jones Futures
(-0.13%) 38 510 points
Nasdaq Futures
(-0.10%) 17 886 points
Oil
(-0.35%) $82.34
Gas
(1.72%) $2.07
Gold
(-1.02%) $2 333.70
Silver
(-2.21%) $27.05
Platinum
(-0.74%) $954.40
USD/EUR
(0.22%) $0.934
USD/NOK
(0.45%) $11.03
USD/GBP
(0.20%) $0.798
USD/RUB
(-0.30%) $93.02

Actualizaciones en tiempo real para Aurinia Pharmaceuticals [AUP.TO]

Bolsa: TSX Industria: Biotechnology
Última actualización31 dic 1970 @ 19:00

-3.51% $ 16.76

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China...

Stats
Volumen de hoy 4.61M
Volumen promedio 314 255
Capitalización de mercado 0.00
EPS $-0.370 ( 2021-08-05 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -11.45
ATR14 $0 (0.00%)

Aurinia Pharmaceuticals Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aurinia Pharmaceuticals Finanzas

Annual 2020
Ingresos: $50.12M
Beneficio Bruto: $-209 000 (-0.42 %)
EPS: $-1.104
FY 2020
Ingresos: $50.12M
Beneficio Bruto: $-209 000 (-0.42 %)
EPS: $-1.104
FY 2019
Ingresos: $318 000
Beneficio Bruto: $-52.55M (-16 524.53 %)
EPS: $-1.330
FY 2018
Ingresos: $463 000
Beneficio Bruto: $-40.92M (-8 837.80 %)
EPS: $-0.760

Financial Reports:

No articles found.

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico